Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3

BACKGROUND: Activation of peroxisome proliferator-activated receptors γ (PPARγ) induces diverse effects on cancer cells. The thiazolidinediones (TZDs), such as troglitazone and ciglitazone, are PPARγ agonists exhibiting antitumor activities; however, the underlying mechanism remains inconclusive. Ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Magenta, Gabriela, Borenstein, Ximena, Rolando, Romina, Jasnis, María Adela
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268944/
https://www.ncbi.nlm.nih.gov/pubmed/18261208
http://dx.doi.org/10.1186/1471-2407-8-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268944/
https://www.ncbi.nlm.nih.gov/pubmed/18261208
http://dx.doi.org/10.1186/1471-2407-8-47

Ejemplares similares